According to studies conducted in May 2026, the trial involved 2,339 participants who received doses of either 4 mg, 9 mg, 12 mg, or a placebo
10.1038/srep39374 Sci
et al: Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
B12 offers benefits such as: reduced risk of heart disease reduced risk of stroke reduced risk of vision loss supporting neurological function healthy cell growth, repair, and reproduction mood regulation healthy digestion A person who eats meat, fish, or dairy usually gets enough B12 from their diet
This promising solution has made headlines for its ability to help people achieve and stay within their target weight
For researchers currently exploring PTD-DBM, this broader momentum provides reassurance that the underlying biological target is widely recognized as valid